165 related articles for article (PubMed ID: 24782178)
1. Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation.
van de Stadt LA; de Vrieze H; Derksen NI; Brouwer M; Wouters D; van Schaardenburg D; Wolbink G; Rispens T
Arthritis Rheumatol; 2014 May; 66(5):1133-40. PubMed ID: 24782178
[TBL] [Abstract][Full Text] [Related]
2. Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Tsang-A-Sjoe MW; Bultink IE; Voskuyl AE; Bentlage AE; Vidarsson G; Wolbink G; Rispens T
J Immunol; 2017 Jan; 198(1):82-93. PubMed ID: 27864476
[TBL] [Abstract][Full Text] [Related]
3. IgG anti-hinge antibodies against IgG4 F(ab')
Ota T; Ota SI; Uchino A; Nagano S
Arthritis Res Ther; 2020 Jun; 22(1):161. PubMed ID: 32586370
[TBL] [Abstract][Full Text] [Related]
4. Elevated Fab glycosylation of anti-hinge antibodies.
Koers J; Derksen N; Falkenburg W; Ooijevaar-de Heer P; Nurmohamed MT; Wolbink GJ; Rispens T
Scand J Rheumatol; 2023 Jan; 52(1):25-32. PubMed ID: 34726124
[TBL] [Abstract][Full Text] [Related]
5. Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis.
Bos WH; Bartelds GM; Vis M; van der Horst AR; Wolbink GJ; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Lems WF; Nurmohamed MT; Aarden L; Hamann D
Ann Rheum Dis; 2009 Apr; 68(4):558-63. PubMed ID: 18445623
[TBL] [Abstract][Full Text] [Related]
6. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
Rheumatology (Oxford); 2008 Oct; 47(10):1489-92. PubMed ID: 18703528
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
8. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
[TBL] [Abstract][Full Text] [Related]
9. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
[TBL] [Abstract][Full Text] [Related]
10. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
12. Anti-citrullinated protein antibodies suppress let-7a expression in monocytes from patients with rheumatoid arthritis and facilitate the inflammatory responses in rheumatoid arthritis.
Lai NS; Yu HC; Yu CL; Koo M; Huang HB; Lu MC
Immunobiology; 2015 Dec; 220(12):1351-8. PubMed ID: 26227320
[TBL] [Abstract][Full Text] [Related]
13. IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.
Lundström SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson PJ; Malmström V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
PLoS One; 2014; 9(11):e113924. PubMed ID: 25426976
[TBL] [Abstract][Full Text] [Related]
14. IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA Responses.
Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Wolbink G; Rispens T
Arthritis Rheumatol; 2015 Dec; 67(12):3124-34. PubMed ID: 26246004
[TBL] [Abstract][Full Text] [Related]
15. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
17. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin.
Chapuy-Regaud S; Nogueira L; Clavel C; Sebbag M; Vincent C; Serre G
Clin Exp Immunol; 2005 Mar; 139(3):542-50. PubMed ID: 15730401
[TBL] [Abstract][Full Text] [Related]
18. 14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
Maksymowych WP; Boire G; van Schaardenburg D; Wichuk S; Turk S; Boers M; Siminovitch KA; Bykerk V; Keystone E; Tak PP; van Kuijk AW; Landewé R; van der Heijde D; Murphy M; Marotta A
J Rheumatol; 2015 Sep; 42(9):1587-94. PubMed ID: 26178283
[TBL] [Abstract][Full Text] [Related]
19. Evading pre-existing anti-hinge antibody binding by hinge engineering.
Kim HS; Kim I; Zheng L; Vernes JM; Meng YG; Spiess C
MAbs; 2016; 8(8):1536-1547. PubMed ID: 27606571
[TBL] [Abstract][Full Text] [Related]
20. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
Farid SSh; Azizi G; Mirshafiey A
Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]